If you liked this article you might like

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More
Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead
Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season
Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock